Skip to main content

Table 1 Antibody information

From: Colon adenoma and adenocarcinoma with clear cell components - two case reports

Antibody Clone Company Dilution Conditioning
CK7 OV-TL 12/30 DAKO, Santa Clara, USA 1:50 Protease
CK20 Ks 20.8 DAKO, Santa Clara, USA 1:50 Protease
CDX2 AMT28 Novus Biologicals, Newcastle, UK 1:50 pH 9.0
CEA II-7 DAKO, Santa Clara, USA 1:40 pH 6.0
CD10 56C6 Novocastra, Newcastle, UK 1:50 pH 6.0 overnight
MUC2 Ccp58 Novocastra, Newcastle, UK 1:100 pH 6.0
MUC5AC CLH2 Abcam, Cambridge, UK 1:1000  
MUC6 CLH5 Novocastra, Newcastle, UK 1:100 pH 6.0
AFP N1501 DAKO, Santa Clara, USA diluted  
Glypican3 1G12 Nichirei Bioscience, Tokyo, Japan diluted pH 9.0
AR AR441 DAKO, Santa Clara, USA 1:25 pH 6.0
Perilipin GP29 PROGEN, Heidelberg, Germany 1:200 pH 6.0
Adipophilin AP125 Acris Antibodies, Herford, Germany 1:10 pH 6.0
Ki67 MIB-1 DAKO, Santa Clara, USA 1:50 pH 6.0
COX2 CX-294 DAKO, Santa Clara, USA 1:100 pH 9.0
APC CC-1 Oncogene, California, USA 1:20 pH 6.0
  1. CK Cytokeratin, CDX2 Caudal type homeobox 2, CEA Carcinoembryonic antigen, CD Cluster differentiation, MUC Mucin, AFP Alpha fetoprotein, AR Androgen receptor, COX2 Cyclooxygenase 2, APC Adenomatous polyposis coli